LARISSA ALEJANDRA MEYER

TitleAssistant Professor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wall JA, Pozzar RA, Enzinger AC, Tavormina A, Howard C, Matulonis UA, Liu JF, Horowitz N, Meyer LA, Wright AA. Improving the palliative-procedure decision-making process for patients with peritoneal carcinomatosis: A secondary analysis. Gynecol Oncol. 2024 Jul 01; 188:125-130. PMID: 38954989.
      Citations:    
    2. Huepenbecker S, Meyer LA, Craft M, Chan JK, Craggs C, Lambert P, Lin YG. Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer. Int J Gynecol Cancer. 2024 Jun 30. PMID: 38950920.
      Citations:    
    3. Wilke RN, Iniesta MD, Fellman B, Jazaeri AA, Meyer LA, Fleming ND, Schmeler KM, Taylor JS. A colostomy for large bowel obstruction at the end of life: What do patients gain from palliative surgery? Gynecol Oncol. 2024 Jun 29; 188:120-124. PMID: 38945019.
      Citations:    
    4. Schuster ALR, Crossnohere NL, Boakye EA, Angove R, Baldwin B, Barreto EA, Chen RC, Gillespie TW, Hamilton B, McCleary NJ, Karmo M, Kaufmann T, Lee W, Mehta V, Meyer L, Mittal K, Owens L, Peterson R, Pusic A, Rainey AM, Richardson A, Shapiro L, Sibbitt B, Smith C, Vargo M, Vickers A, Brundage M, Snyder C. A Framework to Promote Implementation of Patient-Reported Outcomes in Institutions Caring for Vulnerable and Underserved Cancer Populations. Patient. 2024 Jun 22. PMID: 38909128.
      Citations:    Fields:    
    5. Pozzar RA, Enzinger AC, Howard C, Tavormina A, Matulonis UA, Campos S, Liu JF, Horowitz N, Konstantinopoulos PA, Krasner C, Wall JA, Sciacca K, Meyer LA, Lindvall C, Wright AA. Feasibility and acceptability of a nurse-led telehealth intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trial. Gynecol Oncol. 2024 Jun 07; 188:1-7. PMID: 38851039.
      Citations:    Fields:    
    6. Andring LM, Corrigan KL, Reeve B, Meyer L, Wang XS, Smith G, Bailard N, Domingo M, Fellman B, Varkey J, Foster-Mills T, Lin L, Jhingran A, Colbert L, Eifel P, Klopp AH, Joyner M. The value of patient-reported outcomes to predict for symptom burden and health-related quality of life after chemoradiation for cervical cancer: A prospective study. Pract Radiat Oncol. 2024 May 31. PMID: 38825227.
      Citations:    Fields:    
    7. Kamboj M, Bohlke K, Baptiste DM, Dunleavy K, Fueger A, Jones L, Kelkar AH, Law LY, LeFebvre KB, Ljungman P, Miller ED, Meyer LA, Moore HN, Soares HP, Taplitz RA, Woldetsadik ES, Kohn EC. Vaccination of Adults With Cancer: ASCO Guideline. J Clin Oncol. 2024 May 10; 42(14):1699-1721. PMID: 38498792; PMCID: PMC11095883.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    8. Suidan RS, Sun CC, Schneider AK, Lu KH, Giordano SH, Meyer LA. Determination of quality of life-related health utilities for surgical complications in ovarian cancer. Gynecol Oncol. 2024 Jun; 185:101-107. PMID: 38377761.
      Citations:    Fields:    
    9. Knisely A, Iniesta MD, Batman S, Meyer LA, Soliman PT, Cain KE, Marten C, Chisholm G, Schmeler KM, Taylor JS, Fleming ND. Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center. Gynecol Oncol. 2024 Apr; 183:120-125. PMID: 38368180.
      Citations:    Fields:    
    10. Liu W, Meyer L, Morse M, Li Y, Song J, Engle R, Lopez G, Narayanan S, Soliman PT, Ramondetta L, Bruera E, Cohen L. Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients With Ovarian Cancer Receiving Carboplatin-Based Chemotherapy. JCO Oncol Pract. 2024 Apr; 20(4):517-524. PMID: 38301188.
      Citations:    Fields:    
    11. Pozzar RA, Wall JA, Tavormina A, Thompson E, Enzinger AC, Matulonis UA, Campos S, Meyer LA, Wright AA. Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers. Gynecol Oncol. 2024 Feb; 181:68-75. PMID: 38141533; PMCID: PMC10922890.
      Citations:    Fields:    Translation:Humans
    12. Basabe MS, Suki TS, Munsell MF, Iniesta MD, Garcia Lopez JE, Hillman RT, Cain K, Huepenbecker S, Mena G, Taylor JS, Ramirez PT, Meyer LA. Evaluation of a tiered opioid prescription algorithm in an ERAS pathway: exploring opportunities for further refinement. Int J Gynecol Cancer. 2023 Dec 20. PMID: 38123191; PMCID: PMC11186977.
      Citations:    Fields:    
    13. Hinchcliff EM, Knisely A, Adjei N, Fellman B, Yuan Y, Patel A, Xu C, Westin SN, Sood AK, Soliman PT, Shafer A, Fleming ND, Gershenson DM, Vikram R, Bathala T, Vining D, Ganeshan DM, Lu KH, Sun CC, Meyer LA, Jazaeri AA. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer. Cancer. 2024 04 01; 130(7):1061-1071. PMID: 38009662.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    14. Huepenbecker SP, Iniesta MD, Wang XS, Cain KE, Zorrilla-Vaca A, Shen SE, Basabe MS, Suki T, Garcia Lopez JE, Mena GE, Lasala JD, Williams LA, Ramirez PT, Meyer LA. Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy. Am J Obstet Gynecol. 2024 Feb; 230(2):241.e1-241.e18. PMID: 37827271.
      Citations:    Fields:    Translation:Humans
    15. Taylor JS, Iniesta MD, Zorrilla-Vaca A, Cain KE, Lasala JD, Mena GE, Meyer LA, Ramirez PT. Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery. Am J Obstet Gynecol. 2023 08; 229(2):140.e1-140.e7. PMID: 37150284.
      Citations:    Fields:    Translation:Humans
    16. Vranes C, Zhao H, Noer MC, Fu S, Sun CC, Harrison R, Ramirez PT, H?gdall CK, Giordano SH, Meyer LA. Secondary validation of an ovarian cancer-specific comorbidity index in a US population. Int J Gynecol Cancer. 2023 05 01; 33(5):749-754. PMID: 36863760.
      Citations:    Fields:    Translation:Humans
    17. Liang MI, Harrison R, Aviki EM, Esselen KM, Nitecki R, Meyer L. Financial toxicity: A practical review for gynecologic oncology teams to understand and address patient-level financial burdens. Gynecol Oncol. 2023 03; 170:317-327. PMID: 36758422.
      Citations: 1     Fields:    Translation:Humans
    18. Wang XS, Ramirez PT, Shi Q, Kamal M, Garcia-Gonzalez A, Iniesta MD, Cleeland CS, Meyer LA. Patient-reported symptoms at discharge and risk of complications after gynecologic surgery. Int J Gynecol Cancer. 2023 02 06; 33(2):271-277. PMID: 36600503; PMCID: PMC10009896.
      Citations: 1     Fields:    Translation:Humans
    19. Cata JP, Hu J, Feng L, Chung C, Woodman SE, Meyer LA. Association between COVID-19 and Postoperative Neurological Complications and Antipsychotic Medication Use after Cancer Surgery: A Retrospective Study. J Pers Med. 2023 Jan 31; 13(2). PMID: 36836508; PMCID: PMC9959979.
      Citations: 1     
    20. Sidey-Gibbons CJ, Sun C, Schneider A, Lu SC, Lu K, Wright A, Meyer L. Predicting 180-day mortality for women with ovarian cancer using machine learning and patient-reported outcome data. Sci Rep. 2022 12 08; 12(1):21269. PMID: 36481644; PMCID: PMC9732183.
      Citations: 2     Fields:    Translation:Humans
    21. Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LA. Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis. Ann Surg Oncol. 2023 Mar; 30(3):1508-1519. PMID: 36310311; PMCID: PMC10466211.
      Citations: 2     Fields:    Translation:Humans
    22. Hinchcliff E, Rumpf J, Ratan R, Fleming ND, Jazaeri A, Fellman B, Meyer L, Soliman P. Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma. Gynecol Oncol. 2022 Dec; 167(3):490-495. PMID: 36270831.
      Citations: 1     Fields:    
    23. Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma. Front Oncol. 2022; 12:1001150. PMID: 36324592; PMCID: PMC9618687.
      Citations: 3     
    24. Zorrilla-Vaca A, Ramirez PT, Iniesta-Donate M, Lasala JD, Wang XS, Williams LA, Meyer L, Mena GE. Opioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study. Can J Anaesth. 2022 12; 69(12):1477-1492. PMID: 36224506.
      Citations:    Fields:    Translation:Humans
    25. Hayek J, Zorrilla-Vaca A, Meyer LA, Mena G, Lasala J, Iniesta MD, Suki T, Huepenbecker S, Cain K, Garcia-Lopez J, Ramirez PT. Patient outcomes and adherence to an enhanced recovery pathway for open gynecologic surgery: a 6-year single-center experience. Int J Gynecol Cancer. 2022 Oct 06. PMID: 36202425.
      Citations:    Fields:    
    26. Huepenbecker SP, Wright JD, Downer MK, Incerti D, Luhn P, Dolado I, Bastiere-Truchot L, Lin YG, Chan JK, Meyer LA. Temporal Patterns and Adoption of Germline and Somatic BRCA Testing in Ovarian Cancer. Obstet Gynecol. 2022 11 01; 140(5):758-767. PMID: 36201776; PMCID: PMC9588544.
      Citations:    Fields:    Translation:HumansCells
    27. Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Rauh-Hain JA, Fleming ND, Giordano SH, Meyer LA. Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States. Int J Gynecol Cancer. 2022 09 06; 32(9):1153-1163. PMID: 36166208; PMCID: PMC10410715.
      Citations:    Fields:    Translation:Humans
    28. Primm KM, Huepenbecker SP, Zhao H, Sun CC, Hernandez DC, Meyer LA, Chang S. Impacts of Medicaid Expansion on Stage at Cancer Diagnosis by Patient Insurance Type. Am J Prev Med. 2022 12; 63(6):915-925. PMID: 35871117.
      Citations:    Fields:    
    29. Huepenbecker S, Harrison R, Dos Reis R, Pareja R, Iniesta MD, Meyer LA, Frumovitz M, Zorrilla-Vaca A, Ramirez PT, Sant?a MC. Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer. Int J Gynecol Cancer. 2022 Jul 08. PMID: 35803608; PMCID: PMC9825680.
      Citations:    Fields:    
    30. Huepenbecker SP, Sun CC, Fu S, Zhao H, He W, Primm K, Giordano SH, Meyer LA. Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States. Int J Gynecol Cancer. 2022 07 04; 32(7):899-905. PMID: 35331992; PMCID: PMC9256761.
      Citations:    Fields:    Translation:Humans
    31. Fix SM, Sakellariou-Thompson D, Wang Y, Griffiths TM, Lee M, Haymaker CL, Basar R, Reyes C, Kumar S, Meyer LA, Hwu P, Bernatchez C, Jazaeri AA, Forget MA, Dominguez AL. CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-? signaling. J Immunother Cancer. 2022 07; 10(7). PMID: 35882447; PMCID: PMC9330322.
      Citations:    Fields:    Translation:HumansCells
    32. Huepenbecker SP, Meyer LA. How Can We Pursue Equity in Cervical Cancer Prevention With Existing HPV Genotype Differences? J Natl Cancer Inst. 2022 06 13; 114(6):787-789. PMID: 35176166; PMCID: PMC9194615.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    33. Handley KF, Sood AK, Molin GZD, Westin SN, Meyer LA, Fellman B, Soliman PT, Coleman RL, Fleming ND. Frailty repels the knife: The impact of frailty index on surgical intervention and outcomes. Gynecol Oncol. 2022 07; 166(1):50-56. PMID: 35599168.
      Citations:    Fields:    Translation:Humans
    34. Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LA. Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis. Am J Obstet Gynecol. 2022 09; 227(3):482.e1-482.e15. PMID: 35500609; PMCID: PMC9420833.
      Citations:    Fields:    
    35. Huepenbecker SP, Meyer LA. Our dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator. Gynecol Oncol. 2022 04; 165(1):1-3. PMID: 35346424.
      Citations:    Fields:    Translation:Humans
    36. Huepenbecker SP, Zhao H, Sun CC, Fu S, He W, Giordano SH, Meyer LA. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data. JCO Clin Cancer Inform. 2022 03; 6:e2100187. PMID: 35297648; PMCID: PMC8955078.
      Citations:    Fields:    Translation:Humans
    37. Nitecki R, Fu S, Jorgensen KA, Gray L, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Ramirez PT, Rauh-Hain JA. Employment disruption among women with gynecologic cancers. Int J Gynecol Cancer. 2022 01; 32(1):69-78. PMID: 34785522; PMCID: PMC9035315.
      Citations: 1     Fields:    Translation:Humans
    38. Nitecki R, Floyd J, Lamiman K, Clapp MA, Fu S, Jorgensen K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JA. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Cervical Cancer. Obstet Gynecol. 2021 10 01; 138(4):565-573. PMID: 34623068; PMCID: PMC8693797.
      Citations:    Fields:    Translation:Humans
    39. Westin SN, Labrie M, Litton JK, Blucher A, Fang Y, Vellano CP, Marszalek JR, Feng N, Ma X, Creason A, Fellman B, Yuan Y, Lee S, Kim TB, Liu J, Chelariu-Raicu A, Chen TH, Kabil N, Soliman PT, Frumovitz M, Schmeler KM, Jazaeri A, Lu KH, Murthy R, Meyer LA, Sun CC, Sood AK, Coleman RL, Mills GB. Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clin Cancer Res. 2021 12 01; 27(23):6354-6365. PMID: 34518313; PMCID: PMC8639651.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    40. Huepenbecker SP, Iniesta MD, Ramirez PT, Cain KE, Vaughn M, Cata JP, Mena GE, Lasala J, Meyer LA, Zorrilla-Vaca A. Incidence of acute kidney injury after open gynecologic surgery in an enhanced recovery after surgery pathway. Gynecol Oncol. 2021 10; 163(1):191-198. PMID: 34400005; PMCID: PMC8824770.
      Citations:    Fields:    Translation:Humans
    41. Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Giordano SH, Meyer LA. Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States. Cancer. 2021 Nov 15; 127(22):4151-4160. PMID: 34347287; PMCID: PMC8556293.
      Citations: 2     Fields:    Translation:Humans
    42. Huepenbecker S, Hillman RT, Iniesta MD, Chen T, Cain K, Mena G, Lasala J, Wang XS, Williams L, Taylor JS, Lu KH, Ramirez PT, Meyer LA. Impact of a tiered discharge opioid algorithm on prescriptions and patient-reported outcomes after open gynecologic surgery. Int J Gynecol Cancer. 2021 07; 31(7):1052-1060. PMID: 34135073; PMCID: PMC8328052.
      Citations:    Fields:    Translation:Humans
    43. Nitecki R, Clapp MA, Fu S, Lamiman K, Melamed A, Brady PC, Kaimal A, Del Carmen MG, Woodard TL, Meyer LA, Giordano SH, Ramirez PT, Rauh-Hain JA. Outcomes of the First Pregnancy After Fertility-Sparing Surgery for Early-Stage Ovarian Cancer. Obstet Gynecol. 2021 06 01; 137(6):1109-1118. PMID: 33957660; PMCID: PMC8141030.
      Citations:    Fields:    Translation:Humans
    44. Harrison RF, Meyer LA. Financial toxicity is common among gynecologic cancer patients. Int J Gynecol Cancer. 2021 06; 31(6):807. PMID: 33962996.
      Citations:    Fields:    Translation:Humans
    45. Nitecki R, Fleming ND, Fellman BM, Meyer LA, Sood AK, Lu KH, Rauh-Hain JA. Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol. 2021 06; 161(3):660-667. PMID: 33867146; PMCID: PMC8165031.
      Citations:    Fields:    Translation:Humans
    46. Fleming ND, Westin SN, Rauh-Hain JA, Soliman PT, Fellman BM, Coleman RL, Meyer LA, Shafer A, Cobb LP, Jazaeri A, Lu KH, Sood AK. Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer. Gynecol Oncol. 2021 07; 162(1):65-71. PMID: 33838925; PMCID: PMC8287765.
      Citations: 1     Fields:    Translation:Humans
    47. Harrison RF, Fu S, Sun CC, Zhao H, Lu KH, Giordano SH, Meyer LA. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer. Am J Obstet Gynecol. 2021 07; 225(1):68.e1-68.e11. PMID: 33549538; PMCID: PMC8254740.
      Citations: 1     Fields:    Translation:Humans
    48. Coleman RL, Hu W, Soliman P, Nick A, Ramirez PT, Westin SN, Garcia ME, Zhu Z, Palancia J, Fellman BM, Yuan Y, Ram P, Bischoff F, Schmeler K, Bodurka D, Meyer LA, Sood AK. Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study. Gynecol Oncol. 2021 04; 161(1):104-112. PMID: 33551196.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    49. Harrison RF, Cantor SB, Sun CC, Villanueva M, Westin SN, Fleming ND, Toumazis I, Sood AK, Lu KH, Meyer LA. Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2021 04; 161(1):56-62. PMID: 33536126; PMCID: PMC8247119.
      Citations:    Fields:    Translation:Humans
    50. Wang XS, Kamal M, Chen TH, Shi Q, Garcia-Gonzalez A, Iniesta MD, Cleeland CS, Gottumukkala V, Meyer LA. Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery. Gynecol Oncol. 2021 04; 161(1):83-88. PMID: 33536127; PMCID: PMC7994186.
      Citations: 1     Fields:    Translation:Humans
    51. Lasala J, Mena GE, Iniesta MD, Cata J, Pitcher B, Wendell W, Cain K, Basabe M, Suki T, Meyer LA, Ramirez PT, Zorrilla-Vaca A. Impact of anesthesia technique on post-operative opioid use in open gynecologic surgery in an enhanced recovery after surgery pathway. Int J Gynecol Cancer. 2021 04; 31(4):569-574. PMID: 33483432.
      Citations:    Fields:    Translation:Humans
    52. Zhukovsky DS, Haider A, Williams JL, Naqvi S, Joshi N, Mills S, Soliman PT, Mathew B, Bodurka D, Meyer LA, Westin S, Frumovitz M, Nowitz MB, Archie L, Fenton S, Lang K, Boving V, Bruera E. An Integrated Approach to Selecting a Prepared Medical Decision-Maker. J Pain Symptom Manage. 2021 06; 61(6):1305-1310. PMID: 33348030.
      Citations:    Fields:    Translation:Humans
    53. Cain KE, Iniesta MD, Fellman BM, Suki TS, Siverand A, Corzo C, Lasala JD, Cata JP, Mena GE, Meyer LA, Ramirez PT. Effect of preoperative intravenous vs oral acetaminophen on postoperative opioid consumption in an enhanced recovery after surgery (ERAS) program in patients undergoing open gynecologic oncology surgery. Gynecol Oncol. 2021 02; 160(2):464-468. PMID: 33298309; PMCID: PMC7861133.
      Citations: 1     Fields:    Translation:Humans
    54. Nitecki R, Fu S, Lefkowits C, Smith BD, Meyer LA, Melamed A, Giordano SH, Rauh-Hain JA. Employment disruption following the diagnosis of endometrial cancer. Gynecol Oncol. 2021 01; 160(1):199-205. PMID: 33183765; PMCID: PMC7779695.
      Citations: 2     Fields:    Translation:Humans
    55. Hillman RT, Iniesta MD, Shi Q, Suki T, Chen T, Cain K, Williams L, Wang XS, Taylor JS, Mena G, Lasala J, Ramirez PT, Meyer LA. Longitudinal patient-reported outcomes and restrictive opioid prescribing after minimally invasive gynecologic surgery. Int J Gynecol Cancer. 2021 01; 31(1):114-121. PMID: 33158876; PMCID: PMC8631580.
      Citations: 2     Fields:    Translation:Humans
    56. Fleming ND, Westin SN, Meyer LA, Shafer A, Rauh-Hain JA, Onstad M, Cobb L, Bevers M, Fellman BM, Burzawa J, Bhosale P, Zand B, Jazaeri A, Levenback C, Coleman RL, Soliman PT, Sood AK. Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer. Int J Gynecol Cancer. 2021 01; 31(1):92-97. PMID: 33154095; PMCID: PMC8266398.
      Citations: 1     Fields:    Translation:Humans
    57. Liu W, Qdaisat A, Ferrarotto R, Fuller CD, Guo M, Meyer LA, Narayanan S, Lopez G, Cohen L, Bruera E, Hanna EY, Yeung SJ. Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation. Cancer. 2021 02 15; 127(4):528-534. PMID: 33085092; PMCID: PMC8884478.
      Citations:    Fields:    Translation:Humans
    58. Harrison R, Iniesta MD, Pitcher B, Ramirez PT, Cain K, Siverand AM, Mena G, Lasala J, Meyer LA. Enhanced recovery for obese patients undergoing gynecologic cancer surgery. Int J Gynecol Cancer. 2020 10; 30(10):1595-1602. PMID: 32848023; PMCID: PMC8310617.
      Citations: 1     Fields:    Translation:Humans
    59. Meyer LA, Corzo C, Iniesta MD, Munsell M, Shi Q, Pitcher B, Lasala J, Cain KE, Wang XS, Mena G, Ramirez PT. A prospective randomized trial comparing liposomal bupivacaine vs standard bupivacaine wound infiltration in open gynecologic surgery on an enhanced recovery pathway. Am J Obstet Gynecol. 2021 01; 224(1):70.e1-70.e11. PMID: 32682856.
      Citations: 1     Fields:    Translation:Humans
    60. Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LA. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer. 2020 08; 30(8):1195-1202. PMID: 32616627; PMCID: PMC8328049.
      Citations: 2     Fields:    Translation:Humans
    61. Charlton-Ouw KM, Meyer LA. Reply. J Vasc Surg Venous Lymphat Disord. 2020 07; 8(4):699-700. PMID: 32553657.
      Citations:    Fields:    Translation:Humans
    62. Hinchcliff EM, Meyer LA, Westin SN. Has dose-dense chemotherapy met an ICONic end? Lancet Oncol. 2020 07; 21(7):869-870. PMID: 32615101; PMCID: PMC8284846.
      Citations: 1     Fields:    Translation:Humans
    63. Segarra B, Meyer LA, Malpica A, Bhosale P. Endometrial cancer recurrence at multiple port sites. Int J Gynecol Cancer. 2020 06; 30(6):893-896. PMID: 32371426.
      Citations:    Fields:    Translation:Humans
    64. Stewart KI, Eska JS, Harrison RF, Suidan R, Abraham A, Chisholm GB, Meyer LA, Westin SN, Fleming ND, Frumovitz M, Aloia TA, Soliman PT. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges. Int J Gynecol Cancer. 2020 03; 30(3):352-357. PMID: 31911539; PMCID: PMC7322720.
      Citations: 4     Fields:    Translation:Humans
    65. Harrison R, Zhao H, Sun CC, Fu S, Armbruster SD, Westin SN, Rauh-Hain JA, Lu KH, Giordano SH, Meyer LA. Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. Int J Gynecol Cancer. 2020 02; 30(2):187-192. PMID: 31843871; PMCID: PMC7307445.
      Citations:    Fields:    Translation:Humans
    66. Zhukovsky DS, Soliman PT, Mathew B, Mills S, Bodurka D, Frumovitz M, Meyer LA, Westin S, Nowitz M, Archie L, Fenton S, Lang K, Williams JL, Boving V, Bruera E. Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract. 2019 12; 15(12):e1092-e1097. PMID: 31613720; PMCID: PMC7846063.
      Citations:    Fields:    Translation:Humans
    67. Iniesta MD, Lasala J, Mena G, Rodriguez-Restrepo A, Salvo G, Pitcher B, Washington LD, Harris M, Meyer LA, Ramirez PT. Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery. Int J Gynecol Cancer. 2019 11; 29(9):1417-1424. PMID: 31601647.
      Citations: 8     Fields:    Translation:Humans
    68. Harrison RF, Li Y, Guzman A, Pitcher B, Rodriguez-Restrepo A, Cain KE, Iniesta MD, Lasala JD, Ramirez PT, Meyer LA. Impact of implementation of an enhanced recovery program in gynecologic surgery on healthcare costs. Am J Obstet Gynecol. 2020 01; 222(1):66.e1-66.e9. PMID: 31376395; PMCID: PMC7123521.
      Citations: 5     Fields:    Translation:Humans
    69. Gockley A, Melamed A, Cronin A, Bookman MA, Burger RA, Cristae MC, Griggs JJ, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland J, O'Malley DM, Wright AA. Outcomes of secondary cytoreductive surgery for?patients with platinum-sensitive recurrent ovarian?cancer. Am J Obstet Gynecol. 2019 12; 221(6):625.e1-625.e14. PMID: 31207237.
      Citations: 8     Fields:    Translation:Humans
    70. Dottino JA, He W, Sun CC, Zhao H, Fu S, Lu KH, Meyer LA. Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes. Gynecol Oncol. 2019 08; 154(2):405-410. PMID: 31208738; PMCID: PMC6810571.
      Citations: 11     Fields:    Translation:Humans
    71. Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LA. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia. Am J Obstet Gynecol. 2019 11; 221(5):474.e1-474.e11. PMID: 31128110; PMCID: PMC7069241.
      Citations: 9     Fields:    Translation:Humans
    72. Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LA. Total and out-of-pocket costs of different primary management strategies in ovarian cancer. Am J Obstet Gynecol. 2019 08; 221(2):136.e1-136.e9. PMID: 30965052; PMCID: PMC7392324.
      Citations: 11     Fields:    Translation:Humans
    73. Hillman RT, Sanchez-Migallon A, Meyer LA, Iniesta MD, Cain KE, Siverand AM, Veum SPL, Suki TS, Lasala JD, Ramirez PT. Patient characteristics and opioid use prior to discharge after open gynecologic surgery in an enhanced recovery after surgery (ERAS) program. Gynecol Oncol. 2019 06; 153(3):604-609. PMID: 30902370; PMCID: PMC7066503.
      Citations: 7     Fields:    Translation:Humans
    74. Nelson G, Bakkum-Gamez J, Kalogera E, Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena G, Scott M, Gillis C, Elias K, Huang J, Nygren J, Ramirez PT, Dowdy SC, Wijk L, Ljungqvist O. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int J Gynecol Cancer. 2019 05; 29(4):651-668. PMID: 30877144.
      Citations: 95     Fields:    Translation:Humans
    75. Prescott LS, Taylor JS, Enbaya A, Marten CA, Myers KN, Meyer LA, Ramirez PT, Levenback CF, Bodurka DC, Schmeler KM. Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol. 2019 06; 153(3):597-603. PMID: 30872025; PMCID: PMC6545122.
      Citations: 2     Fields:    Translation:Humans
    76. Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol. 2019 03; 152(3):439-444. PMID: 30876486; PMCID: PMC6662191.
      Citations: 2     Fields:    Translation:Humans
    77. Taylor JS, Zhang N, Rajan SS, Chavez-MacGregor M, Zhao H, Niu J, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecol Oncol. 2019 03; 152(3):452-458. PMID: 30876488; PMCID: PMC7152986.
      Citations: 1     Fields:    Translation:Humans
    78. Wang XS, Shi Q, Williams LA, Cleeland CS, Garcia-Gonzalez A, Chen TY, Shahid DR, Ramirez PT, Iniesta MD, Siverand AM, Meyer LA. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN). Gynecol Oncol. 2019 03; 152(3):492-500. PMID: 30876494; PMCID: PMC6422045.
      Citations: 4     Fields:    Translation:Humans
    79. Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin HK, Nick AM, Williams L, Sun C, Wang XS, Lu KH, Ramirez PT. Comparison of patient reported symptom burden on an enhanced recovery after surgery (ERAS) care pathway in patients with ovarian cancer undergoing primary vs. interval tumor reductive surgery. Gynecol Oncol. 2019 03; 152(3):501-508. PMID: 30876495; PMCID: PMC6422048.
      Citations: 4     Fields:    Translation:Humans
    80. Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK. Women's preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol. 2019 03; 152(3):514-521. PMID: 30876497; PMCID: PMC6422049.
      Citations: 4     Fields:    Translation:Humans
    81. Rauh-Hain JA, Hidrue MK, Gaccione P, Melamed A, Meyer LA, Keating NL, Giordano SH, Rice LW, Birrer MJ, Del Carmen MG. Variation in resource utilization associated with the surgical management of ovarian cancer. Gynecol Oncol. 2019 03; 152(3):587-593. PMID: 30579568; PMCID: PMC6420848.
      Citations: 1     Fields:    Translation:Humans
    82. Taylor JS, He W, Harrison R, Zhao H, Sun CC, Lu KH, Giordano SH, Meyer LA. Disparities in treatment and survival among elderly ovarian cancer patients. Gynecol Oncol. 2018 11; 151(2):269-274. PMID: 30253875; PMCID: PMC6294439.
      Citations: 4     Fields:    Translation:Humans
    83. Fleming ND, Nick AM, Coleman RL, Westin SN, Ramirez PT, Soliman PT, Fellman B, Meyer LA, Schmeler KM, Lu KH, Sood AK. Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer. Obstet Gynecol. 2018 09; 132(3):545-554. PMID: 30095787; PMCID: PMC6105510.
      Citations: 17     Fields:    Translation:Humans
    84. Meyer LA, Lasala J, Iniesta MD, Nick AM, Munsell MF, Shi Q, Wang XS, Cain KE, Lu KH, Ramirez PT. Effect of an Enhanced Recovery After Surgery Program on Opioid Use and Patient-Reported Outcomes. Obstet Gynecol. 2018 08; 132(2):281-290. PMID: 29995737; PMCID: PMC6245646.
      Citations: 25     Fields:    Translation:Humans
    85. Suidan RS, Sun CC, Cantor SB, Mariani A, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA. Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis. Obstet Gynecol. 2018 07; 132(1):52-58. PMID: 29889752; PMCID: PMC6294436.
      Citations: 4     Fields:    Translation:Humans
    86. Meyer LA, He W, Sun CC, Zhao H, Wright AA, Suidan RS, Dottino J, Alejandro Rauh-Hain J, Lu KH, Giordano SH. Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecol Oncol. 2018 09; 150(3):451-459. PMID: 29961559; PMCID: PMC8328050.
      Citations: 16     Fields:    Translation:Humans
    87. Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT. Prospective assessment of patient-reported outcomes in gynecologic cancer patients before and after pelvic exenteration. Gynecol Oncol. 2018 06; 149(3):484-490. PMID: 29622276; PMCID: PMC5986607.
      Citations: 2     Fields:    Translation:Humans
    88. Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, Sun CC, Basen-Engquist KM, Lu KH, Klopp AH. Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer. Int J Gynecol Cancer. 2018 02; 28(2):285-292. PMID: 29303933; PMCID: PMC5921903.
      Citations: 5     Fields:    Translation:Humans
    89. Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN. Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device. Obstet Gynecol. 2018 01; 131(1):109-116. PMID: 29215513; PMCID: PMC5739955.
      Citations: 45     Fields:    Translation:Humans
    90. He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA, Suidan RS. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer. 2017 09; 27(7):1350-1359. PMID: 28574929; PMCID: PMC5862427.
      Citations: 2     Fields:    Translation:Humans
    91. Swanick CW, Eifel PJ, Huo J, Meyer LA, Smith GL. Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecol Oncol. 2017 07; 146(1):87-93. PMID: 28506563; PMCID: PMC5896777.
      Citations: 4     Fields:    Translation:Humans
    92. Taylor JS, Rajan SS, Zhang N, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol. 2017 Jun 01; 35(16):1829-1835. PMID: 28388292; PMCID: PMC5455594.
      Citations: 16     Fields:    Translation:Humans
    93. Cohn DE, Ko E, Meyer LA, Wright JD, Temkin SM, Foote J, Jones NL, Havrilesky LJ. The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. Gynecol Oncol. 2017 04; 145(1):185-191. PMID: 28258763; PMCID: PMC5806693.
      Citations: 1     Fields:    Translation:Humans
    94. Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol. 2017 04; 145(1):55-60. PMID: 28131529; PMCID: PMC5557389.
      Citations: 9     Fields:    Translation:Humans
    95. Meyer LA, Wright AA. Reply to M.S. Copur et al. J Clin Oncol. 2017 03; 35(7):803. PMID: 28029325.
      Citations:    Fields:    Translation:Humans
    96. Meyer LA, Cronin AM, Sun CC, Bixel K, Bookman MA, Cristea MC, Griggs JJ, Levenback CF, Burger RA, Mantia-Smaldone G, Matulonis UA, Niland JC, O'Malley DM, Wright AA. Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016 11 10; 34(32):3854-3863. PMID: 27601552; PMCID: PMC5477982.
      Citations: 43     Fields:    Translation:Humans
    97. Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Cristea M, Griggs JJ, Levenback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AA. Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. JAMA Oncol. 2016 Nov 01; 2(11):1427-1433. PMID: 27442965; PMCID: PMC5106306.
      Citations: 16     Fields:    Translation:Humans
    98. Taylor JS, Marten CA, Potts KA, Cloutier LM, Cain KE, Fenton SL, Tatum TN, James DA, Myers KN, Hubbs CA, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss LS, Ware KM, Park AK, Aloia TA, Bodurka DC, Levenback CF, Schmeler KM. What Is the Real Rate of Surgical Site Infection? J Oncol Pract. 2016 10; 12(10):e878-e883. PMID: 27460495; PMCID: PMC5702796.
      Citations: 1     Fields:    Translation:Humans
    99. Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Pract Radiat Oncol. 2017 May - Jun; 7(3):e165-e173. PMID: 27743802.
      Citations: 3     Fields:    Translation:Humans
    100. Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM. The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol. 2017 Feb; 24(2):362-368. PMID: 27573526; PMCID: PMC5557388.
      Citations: 5     Fields:    Translation:Humans
    101. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol. 2016 10; 143(1):3-15. PMID: 27650684; PMCID: PMC5413203.
      Citations: 63     Fields:    Translation:Humans
    102. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, Dizon DS, Kash JJ, Meyer LA, Moore KN, Olawaiye AB, Oldham J, Salani R, Sparacio D, Tew WP, Vergote I, Edelson MI. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 10 01; 34(28):3460-73. PMID: 27502591; PMCID: PMC5512594.
      Citations: 93     Fields:    Translation:Humans
    103. Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GB. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care. 2016; 1(3):231-238. PMID: 30906877; PMCID: PMC6425954.
      Citations: 6     
    104. Rauh-Hain JA, Anders AM, Meyer LA, Clemmer J, Lu KH, Clark RM, Schorge JO, del Carmen MG, Gockley AA. Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis. Int J Gynecol Cancer. 2016 May; 26(4):697-704. PMID: 26825834.
      Citations:    Fields:    Translation:Humans
    105. Nick AM, Meyer LA, Cata J, Lasala J, Mena GE, Gottumukkala V, Iniesta-Donate M, Salvo G, Ramirez PT, Miralpeix E. A call for new standard of care in perioperative gynecologic oncology practice: Impact of enhanced recovery after surgery (ERAS) programs. Gynecol Oncol. 2016 05; 141(2):371-378. PMID: 26906066; PMCID: PMC5989566.
      Citations: 29     Fields:    Translation:Humans
    106. Rauh-Hain JA, Pepin KJ, Meyer LA, Clemmer JT, Lu KH, Rice LW, Uppal S, Schorge JO, Del Carmen MG. Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer. Obstet Gynecol. 2015 Dec; 126(6):1198-1206. PMID: 26551187.
      Citations: 12     Fields:    Translation:Humans
    107. Ramondetta LM, Meyer LA, Schmeler KM, Daheri ME, Gallegos J, Scheurer M, Montealegre JR, Milbourne A, Anderson ML, Sun CC. Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):500-5. PMID: 26498912; PMCID: PMC7418500.
      Citations: 16     Fields:    Translation:Humans
    108. Kim YJ, Munsell MF, Park JC, Meyer LA, Sun CC, Brown AJ, Bodurka DC, Williams JL, Chase DM, Bruera E, Ramondetta LM. Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer. Gynecol Oncol. 2015 Dec; 139(3):553-8. PMID: 26432043; PMCID: PMC8765286.
      Citations: 15     Fields:    Translation:Humans
    109. Rauh-Hain JA, Diver E, Meyer LA, Clemmer J, Lu KH, Del Carmen MG, Schorge JO. Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database. Gynecol Oncol. 2015 Oct; 139(1):77-83. PMID: 26325526.
      Citations: 3     Fields:    Translation:Humans
    110. Rauh-Hain JA, Starbuck KD, Meyer LA, Clemmer J, Schorge JO, Lu KH, Del Carmen MG. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis. Gynecol Oncol. 2015 Oct; 139(1):84-9. PMID: 26307402.
      Citations: 11     Fields:    Translation:Humans
    111. Westin SN, Sun CC, Tung CS, Lacour RA, Meyer LA, Urbauer DL, Frumovitz MM, Lu KH, Bodurka DC. Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv. 2016 Apr; 10(2):261-70. PMID: 26245979; PMCID: PMC4744585.
      Citations: 16     Fields:    Translation:Humans
    112. Wright AA, Cronin A, Milne DE, Bookman MA, Burger RA, Cohn DE, Cristea MC, Griggs JJ, Keating NL, Levenback CF, Mantia-Smaldone G, Matulonis UA, Meyer LA, Niland JC, Weeks JC, O'Malley DM. Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2015 Sep 10; 33(26):2841-7. PMID: 26240233; PMCID: PMC4554746.
      Citations: 66     Fields:    Translation:Humans
    113. Arms RG, Sun CC, Burzawa JK, Fleming ND, Nick AM, Rallapalli V, Westin SN, Meyer LA, Ramirez PT, Soliman PT. Improvement in quality of life after robotic surgery results in patient satisfaction. Gynecol Oncol. 2015 Sep; 138(3):727-30. PMID: 26197762; PMCID: PMC4816594.
      Citations: 6     Fields:    Translation:Humans
    114. Meyer LA, Bohlke K, Powell MA, Fader AN, Franklin GE, Lee LJ, Matei D, Coallier L, Wright AA. Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline. J Clin Oncol. 2015 Sep 10; 33(26):2908-13. PMID: 26150442.
      Citations: 25     Fields:    Translation:Humans
    115. Smith GL, Jiang J, Giordano SH, Meyer LA, Eifel PJ. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):260-7. PMID: 25968823; PMCID: PMC9807029.
      Citations: 11     Fields:    Translation:Humans
    116. Meyer LA, Nick AM, Shi Q, Wang XS, Williams L, Brock T, Iniesta MD, Rangel K, Lu KH, Ramirez PT. Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients. Gynecol Oncol. 2015 Mar; 136(3):440-5. PMID: 25647455; PMCID: PMC4711289.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    117. Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJ. Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Int J Radiat Oncol Biol Phys. 2015 Jan 01; 91(1):196-205. PMID: 25446609.
      Citations: 20     Fields:    Translation:Humans
    118. Jones N, Fleming ND, Nick AM, Munsell MF, Rallapalli V, Westin SN, Meyer LA, Schmeler KM, Ramirez PT, Soliman PT. Conversion from robotic surgery to laparotomy: a case-control study evaluating risk factors for conversion. Gynecol Oncol. 2014 Aug; 134(2):238-42. PMID: 24937481; PMCID: PMC4125462.
      Citations: 7     Fields:    Translation:Humans
    119. Slomovitz BM, Djordjevic B, Westin SN, Iglesias DA, Munsell MF, Jiang Y, Schmandt R, Broaddus RR, Coleman RL, Galbincea JM, Lu KH, Meyer LA. The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer. Int J Gynecol Cancer. 2014 May; 24(4):713-7. PMID: 24651628; PMCID: PMC4039301.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    120. Wang Y, Ye Y, Lin J, Meyer L, Wu X, Lu K, Liang D. Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome. Mol Carcinog. 2015 Jun; 54(6):430-9. PMID: 25867973; PMCID: PMC4869714.
      Citations: 5     Fields:    Translation:Humans
    121. Zhang Q, Celestino J, Schmandt R, McCampbell AS, Urbauer DL, Meyer LA, Burzawa JK, Huang M, Yates MS, Iglesias D, Broaddus RR, Lu KH. Chemopreventive effects of metformin on obesity-associated endometrial proliferation. Am J Obstet Gynecol. 2013 Jul; 209(1):24.e1-24.e12. PMID: 23500454; PMCID: PMC3819145.
      Citations: 21     Fields:    Translation:AnimalsCells
    122. Wang LE, Ma H, Hale KS, Yin M, Meyer LA, Liu H, Li J, Lu KH, Hennessy BT, Li X, Spitz MR, Wei Q, Mills GB. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol. 2012 Mar; 138(3):377-85. PMID: 22146979; PMCID: PMC3526101.
      Citations: 28     Fields:    Translation:HumansCells
    123. Yin J, Lu K, Lin J, Wu L, Hildebrandt MA, Chang DW, Meyer L, Wu X, Liang D. Genetic variants in TGF-? pathway are associated with ovarian cancer risk. PLoS One. 2011; 6(9):e25559. PMID: 21984931; PMCID: PMC3184159.
      Citations: 19     Fields:    Translation:HumansCells
    124. Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol. 2011 Apr; 204(4):355.e1-7. PMID: 21324431; PMCID: PMC4286377.
      Citations: 18     Fields:    Translation:Humans
    125. Yates MS, Meyer LA, Deavers MT, Daniels MS, Keeler ER, Mok SC, Gershenson DM, Lu KH. Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis. Cancer Prev Res (Phila). 2011 Mar; 4(3):463-70. PMID: 21278312; PMCID: PMC3048908.
      Citations: 21     Fields:    Translation:Humans
    126. Lacour RA, Westin SN, Meyer LA, Wingo SN, Schorge JO, Brooks R, Mutch D, Molina A, Sutphen R, Barnes M, Elder J, Teoh D, Powell CB, Choubey V, Blank S, Macdonald HR, Brady MF, Urbauer DL, Bodurka D, Gershenson DM, Lu KH. Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations. Gynecol Oncol. 2011 May 01; 121(2):358-63. PMID: 21276604; PMCID: PMC3310886.
      Citations: 17     Fields:    Translation:Humans
    127. Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res. 2010 Dec 01; 70(23):9765-76. PMID: 21118967; PMCID: PMC5373101.
      Citations: 64     Fields:    Translation:HumansCells
    128. Hennessy BT, Timms KM, Carey MS, Gutin A, Meyer LA, Flake DD, Abkevich V, Potter J, Pruss D, Glenn P, Li Y, Li J, Gonzalez-Angulo AM, McCune KS, Markman M, Broaddus RR, Lanchbury JS, Lu KH, Mills GB. Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer. J Clin Oncol. 2010 Aug 01; 28(22):3570-6. PMID: 20606085; PMCID: PMC2917312.
      Citations: 171     Fields:    Translation:Humans
    129. Meyer LA, Anderson ME, Lacour RA, Suri A, Daniels MS, Urbauer DL, Nogueras-Gonzalez GM, Schmeler KM, Gershenson DM, Lu KH. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol. 2010 May; 115(5):945-952. PMID: 20410767; PMCID: PMC5295824.
      Citations: 48     Fields:    Translation:Humans
    130. Tung CS, Sun CC, Schlumbrecht MP, Meyer LA, Bodurka DC. Survival after intestinal perforation: can it be predicted? Gynecol Oncol. 2009 Dec; 115(3):349-53. PMID: 19765809; PMCID: PMC4254828.
      Citations: 2     Fields:    Translation:Humans
    131. Zhang Q, Shen Q, Celestino J, Milam MR, Westin SN, Lacour RA, Meyer LA, Shipley GL, Davies PJ, Deng L, McCampbell AS, Broaddus RR, Lu KH. Enhanced estrogen-induced proliferation in obese rat endometrium. Am J Obstet Gynecol. 2009 Feb; 200(2):186.e1-8. PMID: 19185100; PMCID: PMC2880878.
      Citations: 12     Fields:    Translation:Animals
    132. Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control. 2009 Jan; 16(1):14-22. PMID: 19078925; PMCID: PMC3693757.
      Citations: 74     Fields:    Translation:HumansAnimalsPHPublic Health
    133. Lacour RA, Daniels MS, Westin SN, Meyer LA, Burke CC, Burns KA, Kurian S, Webb NF, Pustilnik TB, Lu KH. What women with ovarian cancer think and know about genetic testing. Gynecol Oncol. 2008 Oct; 111(1):132-6. PMID: 18684498; PMCID: PMC3746752.
      Citations: 28     Fields:    Translation:Humans
    134. Meyer LA, Westin SN, Lu KH, Milam MR. Genetic polymorphisms and endometrial cancer risk. Expert Rev Anticancer Ther. 2008 Jul; 8(7):1159-67. PMID: 18588460; PMCID: PMC5557368.
      Citations: 13     Fields:    Translation:Humans
    135. Meyer L, Ascher-Walsh CJ, Norman R, Idrissa A, Herbert H, Kimso O, Wilkinson J. Commonalities among women who experienced vesicovaginal fistulae as a result of obstetric trauma in Niger: results from a survey given at the National Hospital Fistula Center, Niamey, Niger. Am J Obstet Gynecol. 2007 Jul; 197(1):90.e1-4. PMID: 17618772.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    136. Meyer L, Pothuri B. Decompressive percutaneous gastrostomy tube use in gynecologic malignancies. Curr Treat Options Oncol. 2006 Mar; 7(2):111-20. PMID: 16455022.
      Citations: 11     Fields:    Translation:Humans
    137. Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004 Dec; 95(3):463-8. PMID: 15581947.
      Citations: 27     Fields:    Translation:Humans
    138. Pothuri B, Meyer L, Gerardi M, Barakat RR, Chi DS. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma. Gynecol Oncol. 2004 Oct; 95(1):193-5. PMID: 15385131.
      Citations: 11     Fields:    Translation:Humans
    139. Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Mansukhani M, Villella J, Meyer L, Schneider A, Gissmann L, Pothuri B, Murty VV, D?rst M. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 2004 May 01; 64(9):2994-7. PMID: 15126331.
      Citations: 76     Fields:    Translation:HumansCells
    140. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. Obstetrical and Gynecological Survey. 71:717-718.
    141. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Practical Radiation Oncology.
    142. A call for new standard of care in perioperative gynecologic oncology practice. Gynecologic Oncology.
    143. The DISINFECT Initiative. Annals of Surgical Oncology. 1-7.
    144. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations missed opportunities. Obstetrical and Gynecological Survey. 65:436-437.
    145. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. Journal of Clinical Oncology. 34:3460-3473.
    146. Patterns of care, predictors, and outcomes of adjuvant therapy for early- and advanced-stage uterine clear cell carcinoma. International Journal of Gynecological Cancer. 26:696-704.
    147. Guidelines for pre- and intra-operative care in gynecologic/oncology surgery. Gynecologic Oncology. 140:313-322.
    148. Postoperative radiation therapy for endometrial cancer. Journal of Oncology Practice. 12:182-185.
    149. What is the real rate of surgical site infection?. Journal of Oncology Practice. 12:e878-e883.
    150. Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer. Journal of Clinical Oncology. 34:3854-3863.
    151. Survivors of gynecologic malignancies. Journal of Cancer Survivorship.
    152. Guidelines for postoperative care in gynecologic/oncology surgery. Gynecologic Oncology.
    153. Use of CA-125 tests and computed tomographic scans for surveillance in ovarian cancer. Obstetrical and Gynecological Survey. 71:660-661.
    154. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer. Gynecologic Oncology. 143:3-15.
    MEYER's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (443)
    Explore
    _
    Co-Authors (90)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _